Consensus (CCSI) Forward Price-to-Revenue Multiple

Corporate emblem and logo of Consensus Cloud Solutions (CCSI)

The forward P/S for Consensus Cloud Solutions (CCSI) is recorded at 1.80 on the current GURU.Markets chart. Expansion for Consensus Cloud Solutions is constrained by global inflation and digital sovereignty. Stable revenue is ensured by its status as the standard in the US digital fax sector. Strong pricing power is based on strict HIPAA regulations, making the software indispensable for clinics.

CCSI Consensus Cloud Solutions Inc: Market Cap to Expected Sales Ratio in the range 07/04/2022 - 11/13/2026

Summary analytical data breakdowns for Consensus Corp (CCSI)

Summary company analytics:CCSI (Consensus Cloud Solutions, Inc.)
Product sample of Consensus Cloud Solutions

The forward P/S ratio relates the current market value of shares to projected revenue for the coming year, allowing for an assessment of business expansion rates. For Consensus Cloud Solutions (CCSI), this indicator reflects the market rate for healthcare digitalization and the transition of clinics to paperless ESG standards. By analyzing the forward P/S chart for Consensus Cloud Solutions (CCSI), an investor can see the valuation trends for cloud services and cybersecurity. This helps determine whether the current price represents a justified premium for technological leadership.

Competitor analysis

Price-to-Projected Revenue Ratio Veeva VEEV|Market Cap to Expected Sales Ratio Doximity Inc (DOCS)|HQY: Forward Price-to-Revenue Multiple|WAY - Forward P/S Multiple|CorVel Corporation (CRVL) - Price-to-Projected Revenue Ratio|PRVA - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple HURN|CERT: Forward Price to Sales|Forward P/S Multiple OMCL|Forward Price-to-Revenue Multiple GoodRx Gold GDRX|Price-to-Projected Revenue Ratio Schrodinger, Inc. SDGR|phreesia.com - Price-to-Projected Revenue Ratio|OMDA - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Evolent Health Inc|HSTM (HealthStream Corp) - Forward Price-to-Revenue Multiple|Definitive Corp (DH) - Forward P/S Multiple|AGL (Agilon Health) - Forward P/S Multiple|Market Cap to Projected Revenue ABSI (absci.com)|Forward Price-to-Revenue Multiple SY (So-Young International Inc.)|NRC (NRC Health) - Forward Price to Sales|Price-to-Projected Revenue Ratio Spok Corp SPOK|Market Cap to Expected Sales Ratio OptimizeRx Inc. (OPRX)|TBRG - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio simulations-plus.com|sophiagenetics.com (SOPH) - Price-to-Projected Revenue Ratio|HCAT (Health Catalyst Inc.) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple CCLD|Forward P/S Multiple Research Solutions Inc.|Forward Price-to-Revenue Multiple DLHC (DLH Holdings Corp.)|Price to Expected Revenue Ratio ONMD|Forward P/S Multiple SCNX (Scienture)|Market Cap to Expected Sales Ratio Healthcare Triangle Inc (HCTI)|ISPC - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Bullfrog AI Holdings|SCWorx Corp. (WORX) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue MSPR|Price-to-Projected Revenue Ratio iCoreConnect, Inc.|TRxADE HEALTH Inc (MEDS) - Market Cap to Expected Sales Ratio|Forward P/S Multiple ORGS|Forward Price-to-Revenue Multiple r1rcm.com RCM|Forward P/S Multiple SHCR (Sharecare, Inc.)|STRM - Forward Price-to-Revenue Multiple|SYRA - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio Apollo Medical Holdings AMEH|MODN: Forward P/S Multiple|NXGN - Market Cap to Expected Sales Ratio